#ASH25#mmsm@ASH_hematology
Oral-myeloma
Danish ABCD Study-prophylactic Tocilizumab RW data
➡️ prophylactic Tocilizumab decreased both G1 and G2 CRS (69% to 7.5%)👇
➡️No difference in efficacy between both groups
Long-awaited study! Results of phase III trial comparing pona + blin vs imatinib + chemo. I wish pona was in both arms. Benefit of chemo-free regimen (TKI + blin) is now confirmed in a phase III study.
@ASH_hematology#ASH25#ASH2025
Reportero: "¿Es aceptable ponerle piña a la pizza?"
Federico Chiesa: "Me da igual."
Reportero: "¿Puedo tomarme un capuchino después de las 12?"
Federico Chiesa: "Me da igual."
Reportero: "Si fuera a tu casa, ¿cuál sería tu plato estrella?"
Federico Chiesa: "No vengas a mi casa."